HUGE (FSD Pharma Inc.) Net earnings per share (EPS TTM)

FSD Pharma (HUGE) - corporate logo

FSD Pharma Inc. (HUGE) develops advanced small molecules to combat neurological pathologies. The team attracts top researchers through a flexible culture and stock options. The company's bioengineering focuses on protecting neurons during depression and dementia. The one-year EPS TTM trend reflects the asset's reaction to Fed policy, while 4.00 determines the latest earnings per share valuation metric.

FSD Pharma - HUGE Earnings per share for the last twelve months (period 02/11/2024 - 02/20/2024)

HUGE (FSD Pharma, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental company valuation:HUGE FSD Pharma Inc.
Flagship merchandise of FSD Pharma

Assessing the financial stability of FSD Pharma Inc. (HUGE) requires an analysis of earnings per share dynamics. This indicator measures the percentage change in net income on a TTM basis relative to the same period last year. By examining the year-over-year EPS (TTM) comparison, an investor can discern the actual efficiency of the business capitalization. For an issuer in an R&D restructuring phase, this trend confirms the success of an austerity policy. Positive momentum will serve as a signal of recovering market confidence.

Direct competitors

Net earnings per one share for the last twelve months Jazz Pharma|CYTK (Cytokinetics Inc.) - Net earnings per share for the last 12 months|PTC Bio (PTCT) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Scholar Rock|CNTA: Earnings per share for the trailing year|Earnings per share for the last twelve months Dyne Therapeutics (DYN)|EWTX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Rapport Pharma RAPP|Alumis Pharma - Earnings per share for the last twelve months|ZVRA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Contineum Therapeutics, Inc.|LRMR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Capricor Therapeutics CAPR|Net earnings per share for the last 12 months TRDA|Net earnings per one share for the last twelve months Channel PTHS|Earnings per share for the last twelve months MediciNova Inc. (MNOV)|SER - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BTAI (BioXcel Therapeutics Inc)|ProMIS Neurosciences (PMN) - Net earnings per one share for the last twelve months|Apimeds Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AEON Biopharma, Inc.|NLSP (NLS Pharma) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months BNOX|RETA (reatapharma.com) - Net earnings per share (EPS TTM)